Speakers

Mr. Ravshan Amirov

Pushkin IBC. Uzbekistan

Museum Technologies Session:

• Portal "3D. Museums of Samarkand. Virtual tour"
  (Session 5)

Dr. Refael Barkan

Head of Research, Innovation and International Ventures Authority, HIT Holon Institute of Technology

Medicine Session

Dr. Renat R. Letfullin

Department of Physics and Optical Engineering, Rose-Hulman Institute of Technology, Terre Haute, Indiana, USA

Data Science Session:

• Nanomedicine is a Future Medicine
  (Session 19)

Mr. Samariddin Mustafakulov

Director of the Afrasiyab Museum, Uzbekistan

Museum Technologies Session:

• Afrasiyab's mural multimedia program
  (Session 5)

Museum Technologies Session:

• Digital reconstruction of Afrosiab's murals in 3D
  (Session 3, Session 10, Session 16)

Dr. Shavkat Alimov

Lecturer at NUUz National University of Uzbekistan

Complex Analyses Session:

• Significance of Mathematical Physics in the Development of Science and Technology
  (Session 15)

Prof. Shavkat Ayupov

Director of the Institute of Mathematics of the Uzbekistan Academy of Sciences, Tashkent

Complex Analyses Session:

• Local Derivations on Measurable Operators and Commutatitivity
  (Session 15)

Mrs. Tony Levy

External Relations, R&I Support, President office
Chief Coordinator, Balkan & Euro-Asia countries
Lecturer, Faculty of Industrial Engineering and Technology Management

Design Technologies Session & Museum Technologies Session:

• Cultural Heritage National Database Management System
  (Session 3, Session 5, Session 10, Session 16)

Prof. Utkir Abdulloyevich Rozikov

Leading scientific fellow & Professor of The National University of Uzbekistan, Institute of Mathematics, Tashkent

Complex Analyses Session: 

• (Thermo)dynamic systems in biology and physics
  (Session 15)

Dr. Vicktoria Vishnevskia-Dai

Director of the ocular oncology and autoimmune service, The Goldschleger eye institute, Sheba Medical Center, Tel-Aviv University, Israel

Medicine Session:

• New and existing innovations in the diagnosis and treatment of uveal melanoma
  (Session 12, Session 21)
• Retinoblastoma from a lethal to curable disease
  (Session TBD)